Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

The Rybrevant-Lazcluze combo significantly reduced the risk of death by 25% versus Tagrisso in patients with newly diagnosed advanced EGFR-mutated NSCLC, according to data from the phase 3 ...

EAST GRAND FORKS — Hoping to open opportunities for potential homeowners and meet community needs, North Star Neighbors Community Land Trust is expanding into East Grand Forks. “I really like ...

Your body produces the enzyme creatine kinase (CK) or creatine phosphokinase to keep your muscles functioning properly. Healthcare providers use the CK test to check levels of this protein in your ...

Summit Therapeutics' ivonescimab outperforms Keytruda in Phase 3 lung cancer trials. Crucial Western market approval depends ...

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High ... searched for DNA mismatch repair ...

Ring-shaped extrachromosomal DNA is implicated in many cancers. Rachel Brazil talks to the scientists trying to uncover their ...

CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...

Presentation details are below: First in human phase 1 trial of the SRC family kinase inhibitor NXP900 in patients with advanced solid tumors Session Title First-in-Human Phase I Clinical Trials 2 ...

Manager Aziz Hamzaogullari thinks and acts like a long-term investor. His team's "alpha thesis" (or its view of what gives it an edge over the competition) is sound in principle. It holds that ...

Incremental process adjustments, but key challenges persist. Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a ...